Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest Pain
Author(s) -
Stephen J. Nicholls,
W.H. Wilson Tang,
Danielle M. Brennan,
Marie-Luise Brennan,
Shirley Mann,
Steven E. Nissen,
Stanley L. Hazen
Publication year - 2011
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2011.166827
Subject(s) - mace , quartile , myeloperoxidase , troponin i , medicine , chest pain , cardiology , predictive value , predictive value of tests , myocardial infarction , confidence interval , inflammation , conventional pci
Although myeloperoxidase (MPO) monitoring is predictive for cardiovascular outcomes in suspected acute coronary syndromes, the value of serial testing is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom